广谱β-内酰胺酶掷硬币:脓毒症患者分离的广谱产β-内酰胺酶肺炎克雷伯菌的患病率。

Access microbiology Pub Date : 2025-02-19 eCollection Date: 2025-01-01 DOI:10.1099/acmi.0.000962.v3
Beatrice Achan, Tonny Luggya, Robert Innocent Ebwongu, Simon Sekyanzi, Henry Kajumbula
{"title":"广谱β-内酰胺酶掷硬币:脓毒症患者分离的广谱产β-内酰胺酶肺炎克雷伯菌的患病率。","authors":"Beatrice Achan, Tonny Luggya, Robert Innocent Ebwongu, Simon Sekyanzi, Henry Kajumbula","doi":"10.1099/acmi.0.000962.v3","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background.</b> <i>Klebsiella pneumoniae</i> is part of the ESKAPE (<i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>K. pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i> and <i>Enterobacter</i> spp.) group of multidrug-resistant (MDR) pathogens. <i>K. pneumoniae</i> is the leading cause of antimicrobial resistance-associated mortality and the second leading cause of nosocomial bloodstream infections (BSIs), globally and in sub-Saharan Africa. Therefore, it was aimed to determine the antibiotic resistance patterns of <i>K. pneumoniae</i> isolated from blood cultures of patients with features of sepsis at Mulago National Referral Hospital, Uganda. <b>Methods.</b> The cross-sectional study on patients with features of sepsis utilized <i>K. pneumoniae</i> (<i>n</i>=30) isolated from positive blood culture specimens. The antibiotic resistance profile was determined by the Clinical and Laboratory Standards Institute's Kirby-Bauer disc diffusion method, which was used to classify the isolates as susceptible, intermediate and resistant. <i>K. pneumoniae</i> isolates that were resistant to third-generation cephalosporins were subjected to extended-spectrum <i>β</i>-lactamase (ESBL) screening and confirmation using the double-disc synergy test using cefotaxime, ceftazidime, ceftriaxone, cefotaxime-clavulanic acid and ceftazidime-clavulanic acid. The results were analysed for frequencies. <b>Results.</b> <i>K. pneumoniae</i> isolates showed emerging resistance to imipenem at 13% (4 out of 30) followed by amikacin at 17% (5 out of 30). There was intermediate resistance to gentamycin at 60% (18 out of 30). However, <i>K. pneumoniae</i> showed the highest resistance to piperacillin at 100% (30 out of 30) followed by sulphamethoxazole-trimethoprim and cefepime, both showing a percentage of 97% (29 out of 30). Up to 16 out of 30 (53.3%) of <i>K. pneumoniae</i> were positive for ESBL production, whilst 14 out of 30 (46.7%) were negative. <b>Conclusion.</b> There was a high prevalence of antibiotic-resistant <i>ESBL</i>-producing <i>K. pneumoniae</i> isolates from BSI of patients with features of sepsis in Uganda's Mulago National Referral Hospital.</p>","PeriodicalId":94366,"journal":{"name":"Access microbiology","volume":"7 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11840160/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tossing the coin of extended-spectrum β-lactamase: prevalence of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from patients with sepsis.\",\"authors\":\"Beatrice Achan, Tonny Luggya, Robert Innocent Ebwongu, Simon Sekyanzi, Henry Kajumbula\",\"doi\":\"10.1099/acmi.0.000962.v3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background.</b> <i>Klebsiella pneumoniae</i> is part of the ESKAPE (<i>Enterococcus faecium</i>, <i>Staphylococcus aureus</i>, <i>K. pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i> and <i>Enterobacter</i> spp.) group of multidrug-resistant (MDR) pathogens. <i>K. pneumoniae</i> is the leading cause of antimicrobial resistance-associated mortality and the second leading cause of nosocomial bloodstream infections (BSIs), globally and in sub-Saharan Africa. Therefore, it was aimed to determine the antibiotic resistance patterns of <i>K. pneumoniae</i> isolated from blood cultures of patients with features of sepsis at Mulago National Referral Hospital, Uganda. <b>Methods.</b> The cross-sectional study on patients with features of sepsis utilized <i>K. pneumoniae</i> (<i>n</i>=30) isolated from positive blood culture specimens. The antibiotic resistance profile was determined by the Clinical and Laboratory Standards Institute's Kirby-Bauer disc diffusion method, which was used to classify the isolates as susceptible, intermediate and resistant. <i>K. pneumoniae</i> isolates that were resistant to third-generation cephalosporins were subjected to extended-spectrum <i>β</i>-lactamase (ESBL) screening and confirmation using the double-disc synergy test using cefotaxime, ceftazidime, ceftriaxone, cefotaxime-clavulanic acid and ceftazidime-clavulanic acid. The results were analysed for frequencies. <b>Results.</b> <i>K. pneumoniae</i> isolates showed emerging resistance to imipenem at 13% (4 out of 30) followed by amikacin at 17% (5 out of 30). There was intermediate resistance to gentamycin at 60% (18 out of 30). However, <i>K. pneumoniae</i> showed the highest resistance to piperacillin at 100% (30 out of 30) followed by sulphamethoxazole-trimethoprim and cefepime, both showing a percentage of 97% (29 out of 30). Up to 16 out of 30 (53.3%) of <i>K. pneumoniae</i> were positive for ESBL production, whilst 14 out of 30 (46.7%) were negative. <b>Conclusion.</b> There was a high prevalence of antibiotic-resistant <i>ESBL</i>-producing <i>K. pneumoniae</i> isolates from BSI of patients with features of sepsis in Uganda's Mulago National Referral Hospital.</p>\",\"PeriodicalId\":94366,\"journal\":{\"name\":\"Access microbiology\",\"volume\":\"7 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11840160/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Access microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1099/acmi.0.000962.v3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Access microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/acmi.0.000962.v3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景。肺炎克雷伯菌是ESKAPE(粪肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌)多重耐药(MDR)病原体群的一部分。肺炎克雷伯菌是全球和撒哈拉以南非洲地区抗微生物药物耐药性相关死亡的主要原因,也是院内血液感染(bsi)的第二大原因。因此,目的是确定从乌干达穆拉戈国家转诊医院脓毒症患者的血液培养中分离的肺炎克雷伯菌的抗生素耐药性模式。方法。对具有脓毒症特征的患者进行横断面研究,利用从阳性血培养标本中分离的肺炎克雷伯菌(n=30)。采用临床和实验室标准研究所的Kirby-Bauer圆盘扩散法确定抗生素耐药性,并将分离株分为敏感、中间和耐药。采用头孢噻肟、头孢他啶、头孢曲松、头孢噻肟-克拉维酸和头孢他啶-克拉维酸双盘协同试验对对第三代头孢菌素耐药的肺炎克雷伯菌进行广谱β-内酰胺酶(ESBL)筛选和确认。对结果进行频率分析。结果。肺炎克雷伯菌分离株对亚胺培南的耐药率为13%(30分之4),其次是对阿米卡星的耐药率为17%(30分之5)。对庆大霉素的中等耐药率为60%(30人中有18人)。然而,肺炎克雷伯菌对哌拉西林的耐药性最高,为100%(30分之30),其次是磺胺甲氧嘧啶-甲氧苄啶和头孢吡肟,两者的耐药性均为97%(30分之29)。30例肺炎克雷伯菌中有16例(53.3%)产生ESBL阳性,而30例中有14例(46.7%)为阴性。结论。在乌干达的穆拉戈国家转诊医院,从具有败血症特征的患者的BSI中分离出的产生esbl的耐抗生素肺炎克雷伯菌的流行率很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Tossing the coin of extended-spectrum β-lactamase: prevalence of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from patients with sepsis.

Background. Klebsiella pneumoniae is part of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, K. pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) group of multidrug-resistant (MDR) pathogens. K. pneumoniae is the leading cause of antimicrobial resistance-associated mortality and the second leading cause of nosocomial bloodstream infections (BSIs), globally and in sub-Saharan Africa. Therefore, it was aimed to determine the antibiotic resistance patterns of K. pneumoniae isolated from blood cultures of patients with features of sepsis at Mulago National Referral Hospital, Uganda. Methods. The cross-sectional study on patients with features of sepsis utilized K. pneumoniae (n=30) isolated from positive blood culture specimens. The antibiotic resistance profile was determined by the Clinical and Laboratory Standards Institute's Kirby-Bauer disc diffusion method, which was used to classify the isolates as susceptible, intermediate and resistant. K. pneumoniae isolates that were resistant to third-generation cephalosporins were subjected to extended-spectrum β-lactamase (ESBL) screening and confirmation using the double-disc synergy test using cefotaxime, ceftazidime, ceftriaxone, cefotaxime-clavulanic acid and ceftazidime-clavulanic acid. The results were analysed for frequencies. Results. K. pneumoniae isolates showed emerging resistance to imipenem at 13% (4 out of 30) followed by amikacin at 17% (5 out of 30). There was intermediate resistance to gentamycin at 60% (18 out of 30). However, K. pneumoniae showed the highest resistance to piperacillin at 100% (30 out of 30) followed by sulphamethoxazole-trimethoprim and cefepime, both showing a percentage of 97% (29 out of 30). Up to 16 out of 30 (53.3%) of K. pneumoniae were positive for ESBL production, whilst 14 out of 30 (46.7%) were negative. Conclusion. There was a high prevalence of antibiotic-resistant ESBL-producing K. pneumoniae isolates from BSI of patients with features of sepsis in Uganda's Mulago National Referral Hospital.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信